Optimization of Prostate Biopsy - Micro-Ultrasound Versus MRI

NACompletedINTERVENTIONAL
Enrollment

804

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

September 6, 2024

Study Completion Date

November 6, 2024

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

Micro-US Targeted Biopsy

All subjects will be biopsied no matter their arm randomization. In this group, MicroUS targets will be identified and sampled.

DIAGNOSTIC_TEST

MRI Targeted Biopsy

All subjects will be biopsied no matter their arm randomization. In this group, MRI targets will be identified and sampled.

Trial Locations (22)

21205

Johns Hopkins, Baltimore

28010

Madrid ROC, Madrid

29572

Carolina Urologic Research Center, Myrtle Beach

32611

University of Florida Health, Gainsville

39120

University of Magdeburg, Magdeburg

90095

UCLA, Los Angeles

06511

Yale University, New Haven

Unknown

Ordensklinikum Elisabethinen, Linz

Hopital Delta, Brussels

Centre Hospitàlier Martigues, Hôpitaux de Provence, Martigues

L'Institut Mutualiste Montsouris, Paris

University of Brandenburg, Brandenburg

ProUro, Berlin

University of Tuebingen, Tübingen

Humanitas, Milan

Urologica Clinica Bilbao, Bilbao

ICUA Madrid, Madrid

T6G1Z1

University of Alberta, Edmonton

M4N3M5

Sunnybrook Health Sciences Centre, Toronto

M5G 2C4

University Health Network - Princess Margaret Hospital, Toronto

H1T 2M4

Hôpital Maisonneuve-Rosemont, Montreal

H4J 1C5

Hôpital du Sacré-Cœur de Montréal, Montreal

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Exact Imaging

INDUSTRY

lead

Sunnybrook Health Sciences Centre

OTHER

NCT05220501 - Optimization of Prostate Biopsy - Micro-Ultrasound Versus MRI | Biotech Hunter | Biotech Hunter